Application 010515
- Type
- NDA
- Sponsor
- BAUSCH
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ISUPREL | ISOPROTERENOL HYDROCHLORIDE | INJECTABLE;INJECTION | 0.2MG/ML | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N010515-001 | ISUPREL | ISOPROTERENOL HYDROCHLORIDE | 0.2MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD, Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N010515-001 | ISUPREL | 0.2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N010515-001 | ISUPREL | 0.2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N010515-001 | ISUPREL | 0.2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N010515-001 | ISUPREL | 0.2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N010515-001 | ISUPREL | 0.2MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / INJECTION | RLD, Approved before 1982 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N010515-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N010515-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N010515-001 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N010515-001 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N010515-001 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N010515-001 | AP | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N010515-001 | AP | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N010515-001 | AP | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N010515-001 | AP | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N010515-001 | AP | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N010515-001 | AP | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N010515-001 | AP | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N010515-001 | AP | 1 | ea99ee380514… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N010515-001 | AP | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | N010515-001 | AP | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N010515-001 | AP | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N010515-001 | AP | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N010515-001 | AP | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N010515-001 | AP | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N010515-001 | AP | 1 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Isoproterenol hydrochloride | ISOPROTERENOL HYDROCHLORIDE | KVK-Tech, Inc. | 051acbc2-7bf8-4059-e063-6394a90a115b | 2026-03-17 | Warnings, Adverse reactions | ISOPROTERENOL HYDROCHLORIDE |
| Isoproterenol Hydrochloride | ISOPROTERENOL HYDROCHLORIDE | Eugia US LLC | 3e4050e8-7d94-4ed7-951d-1ff818ddadf1 | 2025-12-16 | Warnings, Adverse reactions | ISOPROTERENOL HYDROCHLORIDE |
| Isoproterenol Hydrochloride | ISOPROTERENOL HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | d140b27a-3bf7-4e0f-bb91-02b588184f52 | 2025-06-23 | Warnings, Adverse reactions | ISOPROTERENOL HYDROCHLORIDE |
| Isoproterenol Hydrochloride | ISOPROTERENOL HYDROCHLORIDE | Sagent Pharmaceuticals | d2a9b767-0274-49bf-83cd-2fcce9bedc78 | 2025-01-06 | Warnings, Adverse reactions | ISOPROTERENOL HYDROCHLORIDE |
| isoproterenol hydrochloride | ISOPROTERENOL HYDROCHLORIDE | Gland Pharma Limited | 2581854e-e654-4ac3-98e8-36c9f27748bf | 2024-10-07 | Warnings, Adverse reactions | ISOPROTERENOL HYDROCHLORIDE |
| Isoproterenol Hydrochloride | ISOPROTERENOL HYDROCHLORIDE | Nordic Pharma, Inc. | 046f2941-3bc0-4755-861c-71bedb49e706 | 2024-06-27 | Warnings, Adverse reactions | ISOPROTERENOL HYDROCHLORIDE |
| Isoproterenol Hydrochloride | ISOPROTERENOL HYDROCHLORIDE | Nordic Pharma, Inc. | 124f44db-b6ba-4886-bfc7-8c71e60ac5b4 | 2024-06-20 | Warnings, Adverse reactions | ISOPROTERENOL HYDROCHLORIDE |
| Isoproterenol Hydrochloride | ISOPROTERENOL HYDROCHLORIDE | Avenacy, Inc. | 212af0f4-42c7-425d-8baf-9a2f594289a2 | 2024-05-15 | Warnings, Adverse reactions | ISOPROTERENOL HYDROCHLORIDE |
| ISOPROTERENOL | ISOPROTERENOL HYDROCHLORIDE | Cipla USA Inc. | f724120d-da28-4065-9e05-d7dd6afbb546 | 2024-01-14 | Warnings, Adverse reactions | ISOPROTERENOL HYDROCHLORIDE |
| Isoproterenol Hydrochloride | ISOPROTERENOL HYDROCHLORIDE | Armas Pharmaceuticals Inc. | 56cb205c-8329-454a-a6be-e05e497de81e | 2023-07-27 | Warnings, Adverse reactions | ISOPROTERENOL HYDROCHLORIDE |
| Isoproterenol Hydrochloride | ISOPROTERENOL HYDROCHLORIDE | Amneal Pharmaceuticals LLC | f80ce132-1570-43bf-b4a6-0ffbdea5d218 | 2023-02-22 | Warnings, Adverse reactions | ISOPROTERENOL HYDROCHLORIDE |
| Isoproterenol Hydrochloride | ISOPROTERENOL HYDROCHLORIDE | Micro Labs Limited | 0f6a7651-e7b4-4ada-8ccd-2123d094a113 | 2022-11-14 | Warnings, Adverse reactions | ISOPROTERENOL HYDROCHLORIDE |
| ISOPROTERENOL HYDROCHLORIDE | ISOPROTERENOL HYDROCHLORIDE | Amphastar Pharmaceuticals, Inc. | 86b2455a-0489-405e-bd0b-9f79d3c5350d | 2022-10-01 | Warnings, Adverse reactions | ISOPROTERENOL HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0187-4330 | Isuprel | Isoproterenol hydrochloride | Bausch Health Americas, Inc. | NDA | Current |
| 0187-4330 | Isuprel | Isoproterenol hydrochloride | Bausch Health US LLC | NDA | Current |
| 0187-4330 | Isuprel | Isoproterenol hydrochloride | Bausch Health US LLC | NDA | Current |
| 0187-4330 | Isuprel | Isoproterenol hydrochloride | Bausch Health US LLC | NDA | Current |
| 0187-4330 | Isuprel | Isoproterenol hydrochloride | Bausch Health US LLC | NDA | Current |
| 0187-4330 | Isuprel | Isoproterenol hydrochloride | Valeant Pharmaceuticals North America LLC | NDA | Current |
| 0187-4330 | Isuprel | Isoproterenol hydrochloride | Bausch Health US LLC | NDA | Current |
| 68682-433 | Isoproterenol Hydrochloride | Isoproterenol hydrochloride | Oceanside Pharmaceuticals | NDA AUTHORIZED GENERIC | Current |